|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,150.00 GBX | +0.70% |
|
+0.29% | +12.14% |
| 07-08 | Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs, Effective July 7, 2025 | CI |
| 06-30 | Indivior PLC(NasdaqGS:INDV) added to Russell 3000 Value Index | CI |
| Capitalization | 1.92B 1.64B 1.53B 1.42B 2.63B 165B 2.93B 18.36B 7.02B 77.27B 7.21B 7.06B 283B | P/E ratio 2025 * |
13.5x | P/E ratio 2026 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise value | 1.85B 1.59B 1.48B 1.37B 2.54B 159B 2.82B 17.69B 6.77B 74.48B 6.95B 6.81B 273B | EV / Sales 2025 * |
1.82x | EV / Sales 2026 * | 1.66x |
| Free-Float |
96.11% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Indivior PLC
More recommendations
More press releases
More news
| 1 day | +0.70% | ||
| 1 week | +0.29% | ||
| Current month | +5.93% | ||
| 1 month | +10.42% | ||
| 3 months | +62.88% | ||
| 6 months | +25.78% | ||
| Current year | +12.14% |
| 1 week | 1,084 |  | 1,152 |
| 1 month | 975.5 | | 1,161 |
| Current year | 598.5 | | 1,161 |
| 1 year | 554.5 | | 1,161 |
| 3 years | 554.5 | | 2,020 |
| 5 years | 335 | | 2,020 |
| 10 years | 104.9 | | 2,523 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Ciaffoni
CEO | Chief Executive Officer | 54 | - |
Ryan Preblick
DFI | Director of Finance/CFO | 49 | 2020-06-28 |
Vishal Kalia
COO | Chief Operating Officer | 44 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Juliet Thompson
BRD | Director/Board Member | 58 | 2021-03-23 |
Mark Stejbach
BRD | Director/Board Member | 62 | 2021-03-23 |
Barbara Ryan
BRD | Director/Board Member | 65 | 2022-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.70% | +0.29% | +48.36% | -22.93% | 1.92B | ||
| -0.40% | +2.83% | -25.90% | -34.30% | 57.35B | ||
| -0.20% | -1.16% | -20.16% | -24.08% | 8.81B | ||
| -0.83% | +5.83% | +7.47% | +18.10% | 7.04B | ||
| -0.36% | +4.88% | +17.70% | +115.67% | 6.08B | ||
| -0.71% | +7.55% | +18.43% | +25.70% | 5.6B | ||
| +0.30% | -0.45% | +77.27% | +7.15% | 3.39B | ||
| -0.06% | +3.56% | +15.72% | +14.33% | 2.07B | ||
| +0.36% | +0.27% | -9.89% | +16.12% | 2.06B | ||
| +3.46% | +9.03% | +92.70% | +39.38% | 1.92B | ||
| Average | +0.22% | +2.86% | +22.17% | +15.51% | 9.62B | |
| Weighted average by Cap. | -0.29% | +2.05% | -8.88% | -11.28% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.02B 873M 813M 756M 1.4B 87.59B 1.55B 9.74B 3.72B 41.01B 3.83B 3.75B 150B | 1.06B 907M 845M 786M 1.45B 91.05B 1.61B 10.13B 3.87B 42.63B 3.98B 3.9B 156B |
| Net income | 145M 124M 116M 108M 199M 12.45B 221M 1.39B 530M 5.83B 544M 533M 21.39B | 170M 145M 136M 126M 233M 14.6B 259M 1.62B 621M 6.83B 638M 625M 25.07B |
| Net Debt | -69.36M -59.31M -55.25M -51.38M -94.94M -5.95B -106M -662M -253M -2.79B -260M -255M -10.22B | -164M -140M -131M -122M -225M -14.08B -250M -1.57B -599M -6.59B -615M -603M -24.18B |
More financial data
* Estimated data
Employees
1,041
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-14 | 1,148.33 p | +0.55% | 2,327 |
| 25-07-11 | 1,142.00 p | +0.97% | 147,134 |
| 25-07-10 | 1,131.00 p | +2.26% | 123,263 |
| 25-07-09 | 1,106.00 p | -1.95% | 156,107 |
| 25-07-08 | 1,128.00 p | -1.48% | 194,357 |
Delayed Quote London S.E., July 14, 2025 at 04:59 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.42USD
Average target price
14.58USD
Spread / Average Target
-5.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition